Today: 7 February 2026
Subscribe
Browse Category

Insider Trading News 5 January 2026 - 7 January 2026

RKLB stock price forecast: Rocket Lab slips on insider sales as earnings loom

RKLB stock price forecast: Rocket Lab slips on insider sales as earnings loom

New York, Jan 7, 2026, 14:38 EST — Regular session Rocket Lab Corp shares fell 1.3% to $84.94 in afternoon trade on Wednesday after SEC filings showed CFO Adam C. Spice exercised employee options and sold 1,365,665 shares for about $103.1 million, and chief operations officer Frank Klein sold 100,000 shares for about $7.3 million. Both trades ran under Rule 10b5-1 plans — pre-arranged programs that schedule trades — and the stock has traded between $81.85 and $85.96 in the session. The sales hit as RKLB has become a momentum name. The stock ended Tuesday at a record $86.03 and
7 January 2026
·····
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

New York, January 7, 2026, 12:25 (EST) — Regular session Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks. The move matters now because investors have been bidding up riskier biotech names again, and ADPT tends to swing with that tone. The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF were each up about 2.5% in midday trade. The broader market was also higher, but not by as
7 January 2026
·····
Rocket Lab Corporation stock today: RKLB slides after insider sale filing as rally cools

Rocket Lab Corporation stock today: RKLB slides after insider sale filing as rally cools

New York, January 7, 2026, 11:05 EST — Regular session Rocket Lab Corp shares fell 1.8% on Wednesday after a filing showed its chief operations officer sold stock. RKLB was down $1.53 at $84.50 by 10:54 a.m. EST and had traded between $82.16 and $85.41. The stock has ranged from $14.71 to $86.25 over the past 52 weeks and gives Rocket Lab a market value of about $44.2 billion; analysts’ average 12-month target is $68.75 and the company has a trailing loss per share of about 39 cents, the data showed. Investing.com The disclosure hit a stock that has been
7 January 2026
·····
Rocket Lab stock slips after $103 million insider sale; what RKLB investors watch next

Rocket Lab stock slips after $103 million insider sale; what RKLB investors watch next

New York, January 7, 2026, 10:39 EST — Regular session Rocket Lab shares slid 2.6% to $83.80 in mid-morning trade on Wednesday, a day after the space and defense contractor’s stock logged a sharp jump. The pullback came as recent regulatory filings showed two top executives sold a combined roughly $110 million of shares under preset trading plans. Google+1 The sales matter because Rocket Lab’s rally has turned the stock into a crowded trade, with investors leaning on big government work and a pipeline of new hardware to justify a steep valuation. When insiders sell into that kind of tape
7 January 2026
·····
Astera Labs stock drops after insider sale disclosed; earnings next in focus

Astera Labs stock drops after insider sale disclosed; earnings next in focus

New York, Jan 6, 2026, 21:13 EST — Market closed Astera Labs (ALAB.O) shares closed down 3.6% at $161.01 on Tuesday, a second straight decline after a sharp selloff a day earlier. The stock swung between $151.17 and $168.89 in the session as volume rose to about 8.0 million shares. The move landed as investors continued to crowd into chip names tied to data-center buildouts, pushing the Philadelphia semiconductor index up 2.7% to a fresh high. Astera’s drop, against that backdrop, underscored how quickly sentiment can turn in high-valuation AI infrastructure trades. Reuters A Form 4 filing on Tuesday showed
7 January 2026
·····
Carvana stock edges higher after COO share sales filing puts spotlight on insiders

Carvana stock edges higher after COO share sales filing puts spotlight on insiders

NEW YORK, Jan 6, 2026, 13:22 EST — Regular session Carvana Co. shares were up about 1% at $434.50 on Tuesday, giving the online used-car retailer’s stock a modest lift in regular U.S. trading. The move came after a regulatory filing showed Chief Operating Officer Benjamin Huston exercised stock options and sold 10,000 Class A shares in multiple trades on Jan. 2, after a small share withholding to cover taxes. The transactions were made under a Rule 10b5-1 plan, a preset trading program companies use to schedule trades in advance. SEC Why it matters now: Carvana’s stock has become a
6 January 2026
·····
SEC filings show who’s buying AST SpaceMobile as ASTS stock rallies again

SEC filings show who’s buying AST SpaceMobile as ASTS stock rallies again

New York, January 6, 2026, 10:24 EST Three investment advisers disclosed new or expanded stakes in AST SpaceMobile as the satellite-to-phone company’s shares pushed higher again on Tuesday. The disclosures matter because AST SpaceMobile has become a high-volatility bet on whether satellites can extend mobile coverage beyond cell towers. Form 13F reports, filed each quarter, show stock holdings of big investment managers at the end of the reporting period. ASTS was up about 4.9% at $95.41 by mid-morning in New York, after closing at $90.92 on Monday. The stock traded as high as $92.45 on Monday on about 20.5 million
6 January 2026
·····
Why Ondas Holdings (ONDS) stock is moving today: resale filing, insider sale plan and Jan. 16 investor day

Why Ondas Holdings (ONDS) stock is moving today: resale filing, insider sale plan and Jan. 16 investor day

New York, Jan 6, 2026, 09:59 EST — Regular session Ondas Holdings Inc shares fell about 1% in early trade on Tuesday after the drone and private wireless equipment maker disclosed new filings that could add stock supply to the market. The shares were down about 1% at $12.40 at 9:44 a.m. ET, after closing at $12.53 on Monday, and traded between $12.00 and $12.49. The filings land as investors brace for a company-hosted investor day on Jan. 16, when Ondas said it plans to detail its updated business plan and provide a 2026 financial outlook. The company said the
6 January 2026
····
Legal & General shares edge up after insider buys; LGEN investors eye March results

Legal & General shares edge up after insider buys; LGEN investors eye March results

London, Jan 6, 2026, 09:48 GMT — Regular session Shares in Legal & General Group Plc (LGEN.L) were up about 0.1% at 265.8 pence by 09:23 GMT, after the British insurer disclosed new insider share purchases. (Legal & General share price page) The update lands as investors position for the group’s next results and scrutinise its dividend outlook, a key support for the stock. L&G is widely held by income-focused funds, and even small insider buys can draw attention when the market is looking for confidence signals. It also matters because life insurers tend to trade with interest-rate expectations: they
6 January 2026
···
Carvana stock jumps 7% as insider-sale filings hit; what CVNA investors watch next

Carvana stock jumps 7% as insider-sale filings hit; what CVNA investors watch next

New York, January 5, 2026, 19:44 EST — After-hours Carvana Co shares rose 7.5% to $430.06 on Monday. The stock traded between $400.06 and $434.38, keeping the $400 level in view as a near-term chart support area. The online used-car retailer has been a closely watched momentum name since its late-2025 addition to the S&P 500, a shift that can increase the stock’s visibility and the impact of index-linked flows. Reuters That spotlight matters now with investors resetting positions for 2026 and looking for the next data point that can confirm — or challenge — expectations baked into the stock’s
6 January 2026
····
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

New York, Jan 5, 2026, 15:21 EST — Regular session Shares of NewAmsterdam Pharma Company N.V. fell about 5% to $33.42 in afternoon trading on Monday. The Nasdaq-listed stock hit an intraday low of $32.68 after opening at $35.15. The move followed two Form 144 filings that signaled planned sales by company affiliates. In smaller biotech names, even routine insider activity can sway short-term sentiment when liquidity is thinner. Form 144 is an SEC notice filed before certain holders sell stock under Rule 144, which governs resales of restricted or “control” shares. The filing does not confirm a sale, but
5 January 2026
····
Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

New York, Jan 5, 2026, 13:45 EST — Regular session Astera Labs shares fell 8.4% to $164.50 on Monday, after swinging from a session high near $185 to a low around $162.5. More than 5 million shares had traded by early afternoon. The move matters because Astera has become a high-volatility proxy for investor appetite for AI infrastructure spending, where sentiment can turn quickly on positioning and supply. A sharp reversal early in the year can amplify stop-loss selling and make intraday liquidity more fragile. Insider-selling signals draw extra attention in fast-rising semiconductor names, even when the amounts are small
5 January 2026
·····
1 … 9 10 11 12 13 … 28

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop